Zoliflodacin
CAS 1620458-09-4Small Molecule
Overview
Zoliflodacin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3544978).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Zoliflodacin expires 21 Jan 2034 and exclusivity 12 Dec 2035. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (4'R,6'S,7'S)-17'-fluoro-4',6'-dimethyl-13'-[(4S)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]spiro[1,3-diazinane-5,8'-5,15-dioxa-2,14-diazatetracyclo[8.7.0.02,7.012,16]heptadeca-1(17),10,12(16),13-tetraene]-2,4,6-trione
- Canonical SMILES
- C[C@@H]1CN2[C@H]([C@@H](O1)C)C3(CC4=CC5=C(C(=C42)F)ON=C5N6[C@H](COC6=O)C)C(=O)NC(=O)NC3=O
- InChIKey
- ZSWMIFNWDQEXDT-ZESJGQACSA-N
Verified Supplier Partner
Do you supply Zoliflodacin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.